201 related articles for article (PubMed ID: 19389649)
1. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
Batchvarov VN; Govindan M; Camm AJ; Behr ER
Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
[TBL] [Abstract][Full Text] [Related]
2. Brugada-like changes in the peripheral leads during diagnostic ajmaline test in patients with suspected Brugada syndrome.
Batchvarov VN; Govindan M; Camm AJ; Behr ER
Pacing Clin Electrophysiol; 2009 Jun; 32(6):695-703. PubMed ID: 19545329
[TBL] [Abstract][Full Text] [Related]
3. Ajmaline challenge: to stop or not to stop..
Probst V; Le Marec H
Heart Rhythm; 2009 May; 6(5):632-3. PubMed ID: 19389650
[No Abstract] [Full Text] [Related]
4. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
[TBL] [Abstract][Full Text] [Related]
5. Ajmaline attenuates electrocardiogram characteristics of inferolateral early repolarization.
Roten L; Derval N; Sacher F; Pascale P; Wilton SB; Scherr D; Shah A; Pedersen ME; Jadidi AS; Miyazaki S; Knecht S; Hocini M; Jaïs P; Haïssaguerre M
Heart Rhythm; 2012 Feb; 9(2):232-9. PubMed ID: 21914496
[TBL] [Abstract][Full Text] [Related]
6. ST-Elevation Magnitude Correlates With Right Ventricular Outflow Tract Conduction Delay in Type I Brugada ECG.
Leong KMW; Ng FS; Yao C; Roney C; Taraborrelli P; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Boon Lim P; Harding SE; Peters NS; Kanagaratnam P; Varnava AM
Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038102
[TBL] [Abstract][Full Text] [Related]
7. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
[TBL] [Abstract][Full Text] [Related]
8. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
[TBL] [Abstract][Full Text] [Related]
9. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
[TBL] [Abstract][Full Text] [Related]
10. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
[TBL] [Abstract][Full Text] [Related]
11. Ajmaline challenge in young individuals with suspected Brugada syndrome.
Sorgente A; Sarkozy A; De Asmundis C; Chierchia GB; Capulzini L; Paparella G; Henkens S; Brugada P
Pacing Clin Electrophysiol; 2011 Jun; 34(6):736-41. PubMed ID: 21303388
[TBL] [Abstract][Full Text] [Related]
12. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
[TBL] [Abstract][Full Text] [Related]
13. Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome.
Poli S; Toniolo M; Maiani M; Zanuttini D; Rebellato L; Vendramin I; Dametto E; Bernardi G; Bassi F; Napolitano C; Livi U; Proclemer A
Europace; 2018 Feb; 20(2):234-242. PubMed ID: 28521022
[TBL] [Abstract][Full Text] [Related]
14. Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome.
Letsas KP; Efremidis M; Weber R; Korantzopoulos P; Protonotarios N; Prappa E; Kounas SP; Evagelidou EN; Xydonas S; Kalusche D; Sideris A; Arentz T
Heart Rhythm; 2011 Jun; 8(6):874-8. PubMed ID: 21315837
[TBL] [Abstract][Full Text] [Related]
15. Clinical and electrocardiographic predictors of positive response to the intravenous sodium channel blockers in patients suspected of the Brugada syndrome.
Shahrzad S; Khoramshahi M; Aslani A; Fazelifar AF; Haghjoo M
Int J Cardiol; 2013 May; 165(2):285-90. PubMed ID: 21917337
[TBL] [Abstract][Full Text] [Related]
16. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
[TBL] [Abstract][Full Text] [Related]
17. Novel CineECG Derived From Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients With Brugada Syndrome.
van Dam PM; Locati ET; Ciconte G; Borrelli V; Heilbron F; Santinelli V; Vicedomini G; Monasky MM; Micaglio E; Giannelli L; Mecarocci V; Ćalović Ž; Anastasia L; Pappone C
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008524. PubMed ID: 32755392
[TBL] [Abstract][Full Text] [Related]
18. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of bipolar precordial leads during ajmaline testing for suspected Brugada syndrome.
Batchvarov VN; Govindan M; Macfarlane P; Camm AJ; Behr ER
Heart Rhythm; 2010; 7(2):208-15. PubMed ID: 20129297
[TBL] [Abstract][Full Text] [Related]
20. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
